<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Ways_To_Identify_A_Real_Palbociclib</id>
		<title>Ways To Identify A Real Palbociclib - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Ways_To_Identify_A_Real_Palbociclib"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Ways_To_Identify_A_Real_Palbociclib&amp;action=history"/>
		<updated>2026-05-04T06:05:07Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Ways_To_Identify_A_Real_Palbociclib&amp;diff=156434&amp;oldid=prev</id>
		<title>Curleregypt6: Створена сторінка: Similarly, the mean severity score of simplex cases was higher than familial cases, [https://en.wikipedia.org/wiki/Cilengitide Cilengitide] and the mutation wit...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Ways_To_Identify_A_Real_Palbociclib&amp;diff=156434&amp;oldid=prev"/>
				<updated>2017-03-24T13:20:53Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: Similarly, the mean severity score of simplex cases was higher than familial cases, [https://en.wikipedia.org/wiki/Cilengitide Cilengitide] and the mutation wit...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Similarly, the mean severity score of simplex cases was higher than familial cases, [https://en.wikipedia.org/wiki/Cilengitide Cilengitide] and the mutation with the highest mean severity score, p.T178I, was observed only in simplex cases (n?=?8). Consistent with this observation, the mutation with the lowest mean severity score, p.R672C, was found in predominantly familial cases (8/11 or ?73%). Because the diagnosis of DA2A depends, in part, on the presence of abnormalities other than contractures of the limb, we also estimated severity scores based on limb vs. non-limb traits (Fig. 1). The severity scores for limb traits (P?=?0.0011; ANOVA) and lower limb traits (P?[http://www.selleckchem.com/products/PD-0332991.html Palbociclib clinical trial] severity of ankle, feet, and toe contractures (P?[http://www.selleckchem.com/products/Everolimus(RAD001).html Everolimus ic50] mutations (p.T178I, p.R672H, and p.R672C) and the major, objective phenotypic characteristics of DA2A. Based on the scoring system of phenotypic features that we developed, overall severity varied significantly by genotype with p.T178I being the most severe and p.R672C the least. Specifically, individuals with p.T178I were noted to have more severe contractures of the feet and face as well as scoliosis that often was congenital. The importance of these observations is underscored by the fact that p.T178I, p.R672H, and p.R672C explain more than 90% of the MYH3 mutations that cause DA2A in our cohort and in an additional reported case [Tajsharghi et al., 2008]. Accordingly, most individuals with DA2A can be classified into different phenotypic groups as distinguished by MYH3 genotype. This should facilitate providing families of children with DA2A more accurate information about natural history, thereby empowering them to make more informed decisions about care and treatment.&lt;/div&gt;</summary>
		<author><name>Curleregypt6</name></author>	</entry>

	</feed>